Efficacy of statin therapy: Possible effect of phenytoin

Postgraduate Medical Journal

Volumn 75, Issue 884, 1999, Pages 359-360

  Murphy, M J ^a,b   Dominiczak, M H ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Drug interaction; Phenytoin; Statins

Indexed keywords

ATORVASTATIN; CHOLESTEROL; CYTOCHROME P450; GAMMA GLUTAMYLTRANSFERASE; PHENYTOIN; SIMVASTATIN; STATIN;

ADULT; ARTICLE; CASE REPORT; DRUG METABOLISM; ENZYME BLOOD LEVEL; EPILEPSY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA;

EID: 0032937346     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.75.884.359     Document Type: Article

References (9)

1. Horsmans Y, Deager JP, Van den Berge V, Abrassart M, Harvengt C. Effects of simvastatin and pravastatin on 6β-hydroxycortisol excretion a potential marker of cytochrome P450 3A. Pharmacol Res 1993;28:243-7.
2. Sandoz Limited. Lescol® Data Sheet. December 1993.
3. Parke-Davis & Co. Lipitor® Data Sheet. December 1996.
4. Slack J. Risks of ischaemic heart disease in familial hyperlipoproteinaemia states. Lancet 1969;ii:1380-2.
5. Mol MJTH, Erkelens DW, Leuvan JAG, Schouten JA, Stalenhoef AFK. Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia. Lancet 1986;i:936-9.
6. Nation RL, Evans AM, Milne RW. Pharmacokinetic drug interactions with phenytoin (part I). Clin Pharmacokinet 1990;18:37-60.
7. Vickers S, Duncan CA, Vyas KP, et al. In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG-CoA reductase. Drug Metab Dispos 1990;18:476-83.
8. Pan HY, DeVault AR, Wang-Iverson D, et al. Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin. J Clin Pharmacol 1990;30:1128-35.
9. Garnett WR. Interactions with hydroxymethylglutarylcoenzyme A reductase inhibitors. Am J Health-Syst Pharm 1995;52:1639-45.